Jon Ogg over at 24/7 Wall Street took a look at the recently published Goldman Sachs Hedge Fund Trend Monitor and noticed the prevalence of biotech names in the top holdings. I tend to stick to my own knitting (i.e. scans) for trading candidates, but some of these charts looked pretty good… especially for large caps.
PCYC — Nice break from $160, but stretched here I think.
GILD — looks ready to make a run. The “change your mind” point is $85.
REGN — already started to make its run… Like any high dollar value stock, support looks to be a fortune away around $430.00.
AMGN — looks prepared to stage an assault on the highs. Use the uptrend line as support… $156.00 looks good.
CELG — Also looks set to resolve to the upside. $107 is a good floor.
Obviously, no matter how good the opportunity looks, exercise prudent risk control/management (i.e., use stops and appropriate position sizing).
Hope it helps.
This content is restricted to site members. If you are an existing user, please log in. New users may register below.